A detailed history of Pictet Asset Management Sa transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 1,809,261 shares of CRBU stock, worth $3.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,809,261
Previous 2,066,176 12.43%
Holding current value
$3.6 Million
Previous $11 Million 29.92%
% of portfolio
0.01%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$4.04 - $5.47 $1.04 Million - $1.41 Million
-256,915 Reduced 12.43%
1,809,261 $7.69 Million
Q1 2023

May 10, 2023

SELL
$4.3 - $7.78 $2.1 Million - $3.79 Million
-487,702 Reduced 19.1%
2,066,176 $11 Million
Q4 2022

Feb 13, 2023

SELL
$5.57 - $11.01 $4.11 Million - $8.11 Million
-737,020 Reduced 22.4%
2,553,878 $16 Million
Q3 2022

Nov 14, 2022

BUY
$5.34 - $12.79 $3.21 Million - $7.7 Million
601,671 Added 22.37%
3,290,898 $34.7 Million
Q2 2022

Aug 09, 2022

BUY
$5.1 - $9.74 $23,862 - $45,573
4,679 Added 0.17%
2,689,227 $14.6 Million
Q1 2022

May 13, 2022

BUY
$8.42 - $15.32 $6.47 Million - $11.8 Million
768,117 Added 40.08%
2,684,548 $24.6 Million
Q4 2021

Feb 10, 2022

SELL
$14.59 - $23.26 $704,346 - $1.12 Million
-48,276 Reduced 2.46%
1,916,431 $28.9 Million
Q3 2021

Nov 12, 2021

BUY
$15.75 - $30.29 $30.9 Million - $59.5 Million
1,964,707 New
1,964,707 $46.9 Million

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $121M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.